retatrutide triple agonist obesity trial ⭐️topline results from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” Triple hormone receptor agonist retatrutide

Find your recommended protein intake Calculate your recommended daily protein needs for weight loss, maintaining weight, or building muscle, based on your current weight and activity level

At one year, patients on Saxenda had an average placebo-corrected weight loss of 12 pounds or about 6% of body weight

Tapsell LC, Hemphill I, Cobiac L, Sullivan DR, Fenech M, Patch CS, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE (2006) Health benefits of herbs and spices: the past, the present, the future

X., Liu, C

Global burden of metabolic dysfunction-associated steatotic liver disease

Fatima A, Maryam A, Nadeem MS, Asmat KN